BETRF (BetterLife Pharma) Ending Cash Position : $0.09 Mil (As of Jul. 2024)

View and export this data going back to 2010. Start your Free Trial

What is BetterLife Pharma Ending Cash Position?

BetterLife Pharma's Ending Cash Position for the quarter that ended in Jul. 2024 was $0.09 Mil.

BetterLife Pharma's quarterly Ending Cash Position increased from Jan. 2024 ($0.03 Mil) to Apr. 2024 ($0.31 Mil) but then declined from Apr. 2024 ($0.31 Mil) to Jul. 2024 ($0.09 Mil).

BetterLife Pharma's annual Ending Cash Position declined from Jan. 2022 ($0.14 Mil) to Jan. 2023 ($0.01 Mil) but then increased from Jan. 2023 ($0.01 Mil) to Jan. 2024 ($0.03 Mil).

BetterLife Pharma Ending Cash Position Historical Data

The historical data trend for BetterLife Pharma's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma Ending Cash Position Chart

BetterLife Pharma Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

Ending Cash Position

Get a 7-Day Free Trial

2.51

0.12

0.14

0.01

0.03

BetterLife Pharma Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Ending Cash Position	Get a 7-Day Free Trial															0.05	0.07	0.03	0.31	0.09

BetterLife Pharma Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

BetterLife Pharma's Ending Cash Position for the fiscal year that ended in Jan. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.006	+	0.022
	=	0.03

BetterLife Pharma's Ending Cash Position for the quarter that ended in Jul. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.309	+	-0.217
	=	0.09

BetterLife Pharma Ending Cash Position Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

BetterLife Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (OTCPK:BETRF) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

NPAU:Germany BETR:Canada

Address

1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6

Website

https://www.abetterlifepharma.com

BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and the European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.

Executives

Barbara-jean Anne Bormann-kennedy	director, officer: President	1188 BROADWAY, SUITE 306, SOMERVILLE MA 02144
Moira Ong	officer: Chief Financial Officer	2392 LAWSON AVENUE, WEST VANCOUVER A1 V7V 2E6
Hassan Salari	director, 10 percent owner	1517 WEST 58TH AVENUE, VANCOUVER A1 V6P 1W6
Ahmad Doroudian	director, officer: Chairman	1275 WEST 6TH AVENUE, VANCOUVER A1 V6H 1A6